US Congress Senate Bill 2514 (Prior Session Legislation)

---

Spectrum: Moderate Partisan Bill (Republican 4-1)
Status: Introduced on March 7 2018 - 25% progression, died in committee
Action: 2018-03-07 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]

PACED Act Preserving Access to Cost Effective Drugs Act This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings before the International Trade Commission. Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court.

PACED Act Preserving Access to Cost Effective Drugs Act

Sen. Tom Cotton [R-AR]	Sen. Claire McCaskill [D-MO]	Sen. David Perdue [R-GA]	Sen. Joni Ernst [R-IA]
Sen. Pat Toomey [R-PA]

Date	Chamber	Action
2018-03-07	Senate	Read twice and referred to the Committee on the Judiciary.

Type	Source
Summary	https://www.congress.gov/bill/115th-congress/senate-bill/2514/all-info
Text	https://www.congress.gov/115/bills/s2514/BILLS-115s2514is.pdf